LDLR and prostate carcinoma: Pseurotin A (PS) is a terrestrial and marine fungal secondary metabolite reported to target hypercholesterolemia and hypercholesterolemia-induced breast and prostate cancer recurrence through the suppression of PCSK9 secretion and PCSK9-LDLR PPI [20,36].